Daly James M bought HALO
October 1, 2026 · Form 4 insider transaction
Daly James M bought 1,169 shares of Halozyme Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
1,169
Price
$0.00
Total value
N/A
InsiderDaly James M
RoleDirector
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateOctober 1, 2026
Filing dateOctober 2, 2026
Shares owned after1,169
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units granted under the Issuer's director compensation program. Each stock unit represents the right to receive one share of common stock and is scheduled to vest on the date of the Issuer's 2027 annual meeting of stockholders.